| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.4M | +65.8% |
| SG&A Expense | $8.1M | +50.9% |
| Operating Income | -$39.5M | -62.5% |
| Pre-tax Income | -$39.2M | -61.4% |
| Income Tax | $17K | -18.4% |
| Net Income | -$39.3M | -61.3% |
| EPS (Basic) | -$1.65 | -32.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $23.4M | +26.2% |
| Total Assets | $23.7M | +25.2% |
| Current Liabilities | $17.2M | +184.4% |
| Total Liabilities | $18.0M | +172.1% |
| Stockholders' Equity | $5.7M | -53.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.3M | -49.4% |
| Financing Cash Flow | $33.2M | +325.7% |